1. Home
  2. INO vs PUSA Comparison

INO vs PUSA Comparison

Compare INO & PUSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inovio Pharmaceuticals Inc.

INO

Inovio Pharmaceuticals Inc.

HOLD

Current Price

$1.25

Market Cap

118.9M

Sector

Health Care

ML Signal

HOLD

Logo Aureus Greenway Holdings Inc. Common Stock

PUSA

Aureus Greenway Holdings Inc. Common Stock

N/A

Current Price

$3.52

Market Cap

101.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
INO
PUSA
Founded
1979
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
118.9M
101.2M
IPO Year
1999
2024

Fundamental Metrics

Financial Performance
Metric
INO
PUSA
Price
$1.25
$3.52
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$6.75
N/A
AVG Volume (30 Days)
3.2M
530.4K
Earning Date
05-08-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
54.18
N/A
EPS
N/A
N/A
Revenue
$42,220,086.00
$2,964,377.00
Revenue This Year
$20,156.19
N/A
Revenue Next Year
$421.95
N/A
P/E Ratio
N/A
N/A
Revenue Growth
19.37
N/A
52 Week Low
$0.56
$2.60
52 Week High
$2.72
$4.45

Technical Indicators

Market Signals
Indicator
INO
PUSA
Relative Strength Index (RSI) 53.35 46.47
Support Level $1.22 $3.16
Resistance Level $1.24 $4.15
Average True Range (ATR) 0.09 0.20
MACD -0.02 -0.03
Stochastic Oscillator 43.24 14.69

Price Performance

Historical Comparison
INO
PUSA

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.

About PUSA Aureus Greenway Holdings Inc. Common Stock

Aureus Greenway Holdings Inc own and operate two public golf country clubs in Florida. The golf country clubs include two golf-courses with over 13,000 yards of combined fairways, clubhouses boasting food and beverage options, aquatic golf ranges, and pro shops to assist any level of golfer and also host local golf leagues, golf-tournaments, and private events. Its golf country clubs is organized into four principal business segments: (i) golf recreation, retail golf products, and equipment and facilities rental, (ii) membership dues, (iii) food and beverage services. and (iv) ancillary services and amenities. All assets of the Company are located in Florida and all revenue is generated from Florida.

Share on Social Networks: